More than half of Americans under the age of 40 surveyed in a recent poll (58.4%) would choose a day without food over a night without sleep. But they might want to hang onto their hamburgers. It seems they aren’t getting enough shut eye, anyway. This is interesting food for thought that led the Sleep Inn® hotel brand to dig deeper into the state of American sleep. The findings were eye-opening. And now the brand that prides itself on better dreams and relaxing rest is asking Americans around the country to take a stand for more sleep and join the “Let’s Sleep Inn” Movement.
“We are launching the “Let’s Sleep Inn” Movement because the Sleep Inn hotel brand recognizes the vital importance of a good night’s rest - for health, happiness and even, perhaps, the American economy. The word ‘Sleep’ is not only in the name of our Sleep Inn hotels, it’s in our brand DNA,” said Anne Smith, vice president of brand strategy for Choice Hotels. “We wanted to learn more about how and when Americans are sleeping. Our survey not only reveals interesting trends about sleep styles and preferences, but also just how much people would be willing to give up or trade for more quality rest.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7267151-sleep-inn-movement/
As a founding voice in the world of holistic wellness, Canyon Ranch® has the wisdom and expertise of spending nearly 40 years helping its guests achieve well-being. Now, the life-enhancement brand that’s built a devoted global following, is finally going global itself.
Under the guidance of the brand’s new Chief Executive Officer, Susan E. Docherty, the Company announced today the development of its first-ever international destination, Canyon Ranch Wellness Resort at Kaplankaya, on a spectacular peninsula of the sun-kissed Aegean coast. The initial phase of the Canyon Ranch development, which will open in July 2016, will include a strikingly modern resort and luxury real estate offerings. The property will integrate the signature wellness and lifestyle programming that has earned Canyon Ranch a famously loyal clientele worldwide.
To view the multimedia release go to:
http://www.multivu.com/players/English/7634751-canyon-ranch-resort-kaplankaya-turkey/
Today, GENYOUth announced the launch of Fuel Up to Play 60 en español, an evolution of its national flagship program. The program encourages Spanish-speaking communities nationwide to live healthier lifestyles through good nutrition and physical activity. Fuel Up to Play 60 launched a redesigned website (FuelUpToPlay60.com) that provides Spanish-language content and materials, extending the reach and access of the program to students, teachers and families across the country. Several organizations have supported the effort, including the PepsiCo Foundation, which has provided a previously announced grant of $550,000 to develop Spanish-language materials and resources. In addition the PepsiCo Foundation will provide another $100,000 for mini-grants for health and wellness activities and programming within Los Angeles Unified School District and Miami-Dade County Public Schools.
Fuel Up to Play 60, a program founded by the National Football League (NFL) and National Dairy Council (NDC), is designed to engage and empower youth to take action for their own health by implementing long-term, positive nutrition and physical activity changes for themselves, their schools and their communities. Studies show that physical fitness may benefit brain health and academic performance, suggesting active kids may do better. However, only 1 in 3 kids are active every day, potentially leaving many at a disadvantage inside and outside of the classroom.
To view the multimedia release go to:
http://www.multivu.com/players/English/7646551-fuel-up-to-play-60/
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.
With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months.
The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
Women love their hair. They devote time, energy and money to helping it feel and look its best. It’s even a means of self-expression, sometimes more so than a woman’s clothing.
BIOTA Botanicals set out to take the pulse of American women regarding how they really feel about their hair – especially as they (and it) ages.
According to the national consumer survey, most women 30+ have already noticed and worry about the density of their hair as they age. In fact, more women are concerned about thinning-damaged hair than they are about going grey (58% vs. 51%).+ Many say that the condition is embarrassing and a clear-cut sign of getting older, and most agree that it’s an unpreventable fate.
Says Kelli Calabrese, renowned health, beauty and lifestyle expert, “The problem with thinning-damaged hair is not always what’s visible,” she says. “It’s how it rocks a woman’s self-esteem. For women, who put so much emotional value on their hair, it can be absolutely devastating for their self image and emotional well-being.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7598951-biota-fall-beauty-tips/
Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, announced today the launch of its Hidden ScarTM Surgery program designed to certify surgeons and establish Centers of Excellence at major cancer centers and hospitals across the country. This innovative program will train surgeons on advanced minimally invasive and minimal access surgical approaches that deliver optimal clinical and aesthetic outcomes for patients. As part of the company’s broader women’s health initiative, Invuity is hosting a Hidden Scar Breast Cancer Surgery training course in advance of the American College of Surgeons (ACS) Clinical Congress.
Invuity aims to transform the surgical treatment of breast cancer with this advanced surgical approach for nipple sparing mastectomies and lumpectomies (breast conserving surgery). Hidden Scar Breast Cancer Surgery expands surgical options for patients, offering superior cosmetic outcomes that can improve their psychological and emotional recovery and enhance quality of life after surgery.1
With growing demand for less invasive alternatives to breast cancer surgery, surgeons need to operate through smaller incisions with limited fields of vision. Invuity’s illumination technology allows surgeons to access and visualize the entire breast cavity through discrete incision locations, enabling surgeons to safely and effectively treat breast cancer while preserving the natural shape of the breast and thereby minimizing and hiding the scars.
To view the multimedia release go to:
http://www.multivu.com/players/English/7644051-invuity-hidden-scar-breast-cancer-surgery-program/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
Globally renowned tennis champion and Supergoop! Co-Owner Maria Sharapova alongside Supergoop! Founder & CEO Holly Thaggard, are proud to announce the launch of Project Black Dot, a new education and activism platform with the singular mission to end the epidemic of skin cancer and improve skin health in America. Maria is the face and champion of this multidimensional platform that focuses on providing consumers with suncare education and activations year round, not just during the traditional “sun” months.
The Project Black Dot platform, which will unveil multiple initiatives throughout the coming year, will kick off today with “Project 1: Permission,” calling attention to current regulations on sunscreen in schools. This initiative will put the power into the hands of parents and schools by providing a simple, sunscreen permission slip which gives children the ability to use and apply sunscreen at school with the goal of obtaining 100,000 signed sunscreen permission slips.
To view the multimedia release go to:
http://www.multivu.com/players/English/7633051-supergoop-project-black-dot/
What does it look like to really live a full life – one that enriches and satisfies, that provides happiness and enables achievement? Abbott is talking to one million people worldwide to find out. And the answers aren’t as simple as you would think.
Does living fully look the same to an accountant in Shanghai as it does to an architect in New Delhi or a street artist in São Paulo? What about a factory worker in Detroit or a new mother in Berlin? In today’s hyperconnected world that is pulling us together in so many ways, how do our cultural differences, life experiences and personalities influence what it means to live a full life?
Early in this quest we’re seeing preliminary trends, like the role health plays in a full life in Shanghai and the importance of family in New York. We’ll have to see if this is confirmed as we go global with our research. The one thing that is becoming apparent is just how personal it gets when we talk to people about life.
This global quest is at the heart of what our company does—finding answers that have helped people live healthier, better lives for more than 125 years.
To view the multimedia release go to:
http://www.multivu.com/players/English/7611051-abbott-live-fully/
The European Head and Neck Society (EHNS) and the Make Sense Campaign, today announced the launch of the Third Annual Head and Neck Cancer Awareness week (21–25 September). Through the pan-European Awareness Week, the EHNS and Make Sense Campaign promote education on head and neck cancer risk factors, disease prevention and disease signs and symptoms for both patients and healthcare professionals.
“Each year 350,000 people are diagnosed with head and neck cancer across Europe, and over half will not be alive after five years. However, if diagnosed and treated earlier, patients can have an 80 – 90% survival rate.” said Professor René Leemans, President of the EHNS and Professor and Chief of Otolaryngology – Head and Neck Surgery at VU University Medical Centre. “Through the Make Sense Campaign we are educating people about the early signs of the disease and encouraging them to seek professional help in a timely manner. Additionally, we are advocating for the best possible standards of patient care so that their outcomes can be optimised once they have been diagnosed with the disease.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7628151-support-head-neck-cancer-patients/
In an agreement announced today at Chicagoland Speedway, Aspen Dental Management, Inc. (ADMI) has extended its partnership with Danica Patrick and Stewart Haas Racing (SHR), doubling the number of races in which Aspen Dental serves as primary sponsor. The deal means that Patrick will be behind the wheel of the blue-and-white No. 10 Aspen Dental Chevrolet SS for four races annually beginning with the 2016 NASCAR Sprint Cup Series season, with associate sponsorship status for Patrick in all other Sprint Cup races.
“Working with Aspen Dental dentists has been a real pleasure,” Patrick said. “I love partnering with organizations that care about people, and teaming up with an organization that has such an important mission – breaking down barriers and helping patients get the dental care they need – is very rewarding. Aspen Dental dentists raise awareness about the importance of oral health every day, and I look forward to shining a spotlight on the great work they do.”
Aspen Dental practices are one of the largest and fastest-growing networks of independent dental care providers in the United States, with more than 500 locations across 32 states. In the past two years, Patrick has served as an ambassador for Aspen Dental practices across a multitude of channels, from launching Aspen Dental’s Healthy Mouth Movement, a community-giving initiative to deliver free dental care and oral health education to people in need, to appearing in A Taste of the Future, a hidden camera video designed to raise awareness about the long-term consequences of delaying dental care.
To view the multimedia release go to:
http://www.multivu.com/players/English/7629351-aspen-dental-shr-partnership/
West Pharmaceutical Services, Inc. (NYSE: WST) and HealthPrize Technologies, LLC, today announced the completion of the first two phases of their four-phase strategic collaboration. The companies are working to integrate HealthPrize’s Software-as-a-Service (SaaS) medication adherence and patient-engagement platform with West’s injectable drug delivery systems to provide an end-to-end connected health solution for pharmaceutical companies and the patients they serve. The combined offering will provide voluntary, electronically connected drug delivery systems that track when patients take their medication. The HealthPrize system engages and educates patients to increase adherence and medical literacy, rewarding interaction and compliance with prescribed treatment plans, and contributing to better health outcomes.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7625851-west-pharma-healthprize-tech-collaboration/
